MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Baseline brain inflammation is associated with less cognitive progression at 24 months in subjects with de novo Parkinson’s disease

    T. Yacoubian, N. Stover, M. Dean, A. Amara, L. Ruffrage, H. Qin, E. Benveniste, Y. Fang, J. Mcconathy, Y. Zhang, R. Kennedy, A. Gerstenecker, D. Standaert (Birmingham, USA)

    Objective: To examine if brain inflammation measured by 18F-DPA-714 imaging is associated with cognitive change in subjects with early Parkinson’s disease (PD). Background: Evidence for…
  • 2025 International Congress

    GPi Lesioning vs. DBS: Does Targeting the Same Structure Differently Affect Cognition in Parkinson’s Disease?

    J. Brainer, P. Brainer, S. Laurentino, M. Cavalcanti, A. Oliveira, A. Brainer, P. Brainer (Recife, Brazil)

    Objective: To compare the cognitive and quality of life (QoL) outcomes of GPi-DBS and GPi-RF, investigating whether lesion-based approaches pose a greater cognitive burden over…
  • 2025 International Congress

    Negative Correlation Between Apathy and Performance on Memory Tasks in Patients with Idiopathic Parkinson’s Disease without Dementia.

    J. Felipe Ayala-Rico, C. Alberto Hurtado-González, S. Ospinta-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, K. Valbuena-Epiayu (Cali, Colombia)

    Objective: To establish the impact of apathy on memory functioning in patients with IPDWD. Background: Memory is one of the domains of neurocognitive functioning that…
  • 2025 International Congress

    Psychometric Properties of the SCOPA-Cog Turkish version

    S. Isazade, H. Ozden, D. Gunal (Istanbul, Turkey)

    Objective: The objective of this study is to adapt SCOPA-COG for Turkish-speaking patients with Parkinson's disease, ensuring it is both valid and reliable. This will…
  • 2025 International Congress

    CSF Biomarker-based Cognitive Trajectories in Parkinson’s Disease-Subjective Cognitive Decline

    J. Rodriguez-Antiguedad, A. Puig-Davi, I. Ruiz-Barrio, J. Pagonabarraga, A. Vazquez-Oliver, A. Horta-Barba, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate associations between CSF biomarkers and cognitive decline in Parkinson’s Disease-Subjective Cognitive Decline (PD-SCD). Background: The presence of cognitive complaints without objective cognitive…
  • 2025 International Congress

    Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study

    C. Cerquera-Cleves, G. Pinilla-Monsalve, M. Blais, M. Cressati, C. Normandeau, C. Degroot, I. Kathol, S. Bogard, A. Bendas, R. Camicioli, Z. Gan-Or, DA. Grimes, K. Schoffer, LV. Kalia, PA. Macdonald, MJ. Mckeown, D. Martino, J. Miyasaki, M. Schlossmacher, AJ. Stoessl, A. Strafella, E. Fon, O. Monchi, N. Dupré, F. Cicchetti (Québec, Canada)

    Objective: To evaluate the clinical outcomes associated with pesticide exposure in Parkinson’s disease (PD) participants in the Canadian Open Parkinson Network (COPN)(1). Background: Pesticide exposure…
  • 2025 International Congress

    Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

    M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)

    Objective: We compared the clinical symptoms of early Parkinson's disease (PD) between young-onset and elderly-onset. Background: The progression of PD varies depending on the age…
  • 2025 International Congress

    Ethnicity in Parkinson’s Disease: A Brazilian Cross-sectional Study

    J. Oliveira, G. Nunes, N. Dos Santos, F. Brito, J. Costa, E. Muricy, G. de Vasconcelos, S. Baran, R. Kauark (Salvador, Brazil)

    Objective: To investigate clinical characteristics of PD patients and their association with ethnicity at a reference center for movement disorders. Background: It is well known…
  • 2025 International Congress

    The Unique Clinical Profile of Dystonia in Parkinson Disease

    L. Xavier, A. Eid, H. Hwang, J. Perlmutter, P. Kotzbauer, M. Campbell, S. Norris (Saint Louis, USA)

    Objective: Characterize clinical features of dystonia and levodopa-related dyskinesias in Parkinson disease (PD). Background: Dystonia affects 30-60% of individuals with PD. [1] Despite recognition as…
  • 2025 International Congress

    The Movement Disorders Society Unified Parkinson Disease Rating Scale Motor Subscore Is Not Associated With Future Parkinson Disease Milestones – an observational study using linked health administrative data

    P. Gros, S. Bronskill, S. Dorrance, X. Wang, M. Chiu, M. Farkouh, C. Marras (Toronto, Canada)

    Objective: To examine the association between time to Parkinson Disease (PD) health administrative data milestones and a one-year change in the Movement Disorders Society –…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley